370 related articles for article (PubMed ID: 24738333)
1. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
[TBL] [Abstract][Full Text] [Related]
2. [Influence of Fe₃O₄Magnetic Nanoparticles Combined with As2O3 and Adriamycin on Raji Cell Apoptosis and Autophagy].
Wang CL; Cai XH; Zhang LJ; He ZM; Sheng F; Cheng J; Zhang Y; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1318-24. PubMed ID: 26524030
[TBL] [Abstract][Full Text] [Related]
3. Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe3O4 magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells.
Zhang W; Qiao L; Wang X; Senthilkumar R; Wang F; Chen B
Int J Nanomedicine; 2015; 10():3275-89. PubMed ID: 25995634
[TBL] [Abstract][Full Text] [Related]
4. [Effect of arsenic trioxide combined with adriamycin on the proliferation and apoptosis of human lymphoma cells].
Huang R; Li X; Huang X; Yang X; Li W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):515-22. PubMed ID: 19587434
[TBL] [Abstract][Full Text] [Related]
5. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
6. [Reversal effect of Fe3O4-magnetic nanoparticles on multi-drug resistance of ovarian carcinoma cells and its correlation with apoptosis-associated genes].
Jiang Z; Chen BA; Wu Q; Xia GH; Zhang Y; Gao F; Hong TY; Xu CR; Cheng J; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Ai Zheng; 2009 Nov; 28(11):1158-62. PubMed ID: 19895735
[TBL] [Abstract][Full Text] [Related]
7. Preparation and anti-Raji lymphoma efficacy of a novel pH sensitive and magnetic targeting nanoparticles drug delivery system.
Cai X; Yu X; Qin W; Wang T; Jia Z; Xiao R; Qi C
Bioorg Chem; 2020 Jan; 94():103375. PubMed ID: 31718892
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression.
Song L; Zhang W; Chen H; Zhang X; Wu H; Ma M; Wang Z; Gu N; Zhang Y
Int J Nanomedicine; 2019; 14():921-936. PubMed ID: 30787607
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
[TBL] [Abstract][Full Text] [Related]
10. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis.
Zhao H; Guo W; Peng C; Ji T; Lu X
Mol Biol Rep; 2010 Jun; 37(5):2509-15. PubMed ID: 19701692
[TBL] [Abstract][Full Text] [Related]
12. [In vitro effect of bortezomib alone or in combination with harringtonine or arsenic trioxide on proliferation and apoptosis of multidrug resistant leukemia cells].
Cai YX; Meng FY; Sun QX; Fu YB; Li L
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):737-40. PubMed ID: 19176009
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.
Zhang XH; Feng R; Lv M; Jiang Q; Zhu HH; Qing YZ; Bao JL; Huang XJ; Zheng XL
Leuk Res; 2013 Dec; 37(12):1719-25. PubMed ID: 24211095
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
15. [Apoptosis and cell cycle arrest in lymphoma Raji cells induced by arsenic trioxide].
Long Y; Li HM; Qing C; Yu MJ; Zhang YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1320-4. PubMed ID: 19099636
[TBL] [Abstract][Full Text] [Related]
16. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.
Lu D; Bai XC; Gui L; Li M; Zheng WS; Han XQ; Luo SQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):997-1001. PubMed ID: 14559676
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of As2O3 induces apoptosis of glioma U87 cells.
Wang GB; Liu JH; Hu J; Xue K
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4875-4881. PubMed ID: 29164574
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway.
Wang DH; Wei HL; Zhao HS; Hao CY; Min ZH; Liu JM
Pharmacol Res; 2005 Nov; 52(5):376-85. PubMed ID: 15979894
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction.
Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
Cancer Biol Ther; 2007 Apr; 6(4):580-6. PubMed ID: 17374990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
